Pretreatment with quinpirole inhibits the central antihypertensive effects of rilmenidine and α-methyldopa in conscious rats

European Journal of Pharmacology

Volumn 322, Issue 2-3, 1997, Pages 191-199

  Van Den Buuse, Maarten ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Dopamine; Dopamine D2 receptor; Hydralazine; Quinpirole; Rilmenidine; Sympathetic nervous system; Vasopressin; Methyldopa

Indexed keywords

CLONIDINE; DOMPERIDONE; DOPAMINE 2 RECEPTOR; HYDRALAZINE; METHYLDOPA; QUINPIROLE; RACLOPRIDE; RILMENIDINE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DRUG ACTIVITY; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0030972660     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00009-5     Document Type: Article

References (37)

1. Chiu, E.K.Y. and J.R. McNeill, 1985, Vasopressin withdrawal produces hypotension in the spontaneously hypertensive rat, Am. J. Physiol. 249, H193.
2. Chiu, E.K.Y. and J.R. McNeill, 1986, The effect of prolonged infusion and withdrawal of angiotensin II in the spontaneously hypertensive rat, Can. J. Physiol. Pharmacol. 64, 748.
3. Clemens, J.A., T. Okimura and E.B. Smalstig, 1993, Dopamine agonist activities of pergolide, its metabolites, and bromocriptine as measured by prolactin inhibition, compulsive turning, and stereotypic behavior, Arzneim.-Forsch. Drug Res. 43, 281.
4. Cornish, J.L. and M. Van den Buuse, 1995, Stimulation of the rat mesolimbic dopaminergic system produces a pressor response which is mediated by dopamine D-1 and D-2 receptor activation and the release of vasopressin, Brain Res. 701, 28.
5. Cornish, J.L., D.P. Wilks and M. Van den Buuse, 1997, A functional interaction between the brain mesolimbic dopaminergic system and vasopressin release in the regulation of blood pressure, Neuroscience (in press).
6. Cunningham, E.T. and P.E. Sawchenko, 1991, Reflex control of magnocellular vasopressin and oxytocin secretion, Trends Neurosci. 14, 406.
7. Eilam, D. and H. Szechtman, 1989, Biphasic effect of D-2 agonist quinpirole on locomotion and movements, Eur. J. Pharmacol. 161, 151.
8. Esler, M., F. Dudley, G. Jennings, H. Debinski, G. Lambert, P. Jones, B. Crotty, J. Colman and I. Willett, 1992, Increased sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis, Ann. Intern. Med. 116, 446.
9. Franklin, R.B., G.S. Sittampalam, K.H. Valia and J.F. Quay, 1994, Disposition of C-quinelorane in dogs following oral or intravenous dosing and transdermal patch application, Drug Dev. Ind. Pharm. 20, 1439.
10. 3H]quinpirole binding sites in the rat brain, Synapse 14, 113.
11. Head, G.A., 1995, Central monoamine systems and new antihypertensive agents, Clin. Exp. Hypertens. 17, 141.
12. Head, G.A. and R. McCarty, 1987, Vagal and sympathetic components of the heart rate range and gain of the baroreceptor-heart rate reflex in conscious rats, J. Auton. Nerv. Syst. 21, 203.
13. Hirooka, Y., G.A. Head, P.D. Potts, S.J. Godwin, R.D. Bendle and R.A.L. Dampney, 1996, Medullary neurons activated by angiotensin II in the conscious rabbit, Hypertension 27, 287.
14. 2 receptor agonist, lowers blood pressure in the conscious rat, Pharmacology 35, 194.
15. Kirouac, G.J. and P.K. Ganguly, 1993, Up-regulation of dopamine receptors in the brain of the spontaneously hypertensive rat: an autoradiographic analysis, Neuroscience 52, 135.
16. Lancranjan, I., 1981, The endocrine profile of bromocriptine: its application in endocrine diseases, J. Neural Transm. 51, 61.
17. 2 receptors on rat vagal afferent neurones, Br. J. Pharmacol. 114, 1329.
18. 2 receptor agonist quinpirole on the in vivo release of dopamine in the caudate nucleus of hypertensive rats, Eur. J. Pharmacol. 201, 125.
19. Malpas, S.C., G.A. Head and W.P.A. Anderson, 1996, Renal responses to increases in renal sympathetic nerve activity induced by brainstem stimulation in rabbits, J. Auton. Nerv. Syst. 61, 70.
20. McNay, J.L., D.P. Henry and A.F. De Long, 1987, LY171555, a selective dopamine (DA-2) agonist, increases the blood pressure of hypertensive patients, Clin. Exp. Hypertens. A9, 1098.
21. Mizuno, Y., T. Kondo and H. Narabayashi, 1995, Pergolide in the treatment of Parkinson's disease, Neurology 45, 13.
22. Montastruc, J.L., O. Rascol and J.M. Senard, 1993, Current status of dopamine agonists in Parkinson's disease management, Drugs 46, 384.
23. 2 receptor agonist, in the conscious rat, J. Pharmacol. Exp. Ther. 236, 735.
24. 2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats, J. Pharmacol. Exp. Ther. 242, 143.
25. 2-adrenoreceptor agonists in anesthetized cats, Br. J. Pharmacol. 98, 1157.
26. Renaud, L.P. and C.W. Bourque, 1991, Neurophysiology and neuropharmacology of hypothalamic magnocellular neurons secreting vasopressin and oxytocin, Prog. Neurobiol. 36, 131.
27. Silverman, A.J. and E.A. Zimmerman, 1983, Magnocellular neurosecretory system, Annu. Rev. Neurosci. 6, 357.
28. Swanson, L.W. and P.E. Sawchenko, 1983, Hypothalamic integration: organisation of the paraventricular and supraoptic nuclei, Annu. Rev. Neurosci. 6, 269.
29. Urano, A. and H. Kobayashi, 1978, Effects of noradrenaline and dopamine injected into the supraoptic nucleus on urine flow in hydrated rats, Exp. Neurol. 60, 140.
30. Van den Buuse, M., 1992, Central effects of quinpirole on blood pressure of spontaneously hypertensive rats, J. Pharmacol. Exp. Ther. 262, 303.
31. Van den Buuse, M., 1993, Effects of 7-hydroxy-N,N-di-n-propylaminotetralin on behaviour and blood pressure of spontaneously hypertensive rats, Eur. J. Pharmacol. 243, 169.
32. Van den Buuse, M., 1995, Differential effects of quinelorane and pergolide on behaviour, blood pressure, and body temperature of spontaneously hypertensive rats and Wistar-Kyoto rats, Pharmacol. Biochem. Behav. 50, 389.
33. Van den Buuse, M. and W. De Jong, 1992, Pharmacology of central dopaminergic modulation in hypertension, in: Antihypertensive Drugs Today, Vol. 2, eds. H. Saito, M. Minami and S.H. Parvez (VSP Press, Utrecht, Tokyo) p. 157.
34. Van den Buuse, M. and S. Itoh, 1993, Central effects of endothelin on baroreflex of spontaneously hypertensive rats, J. Hypertens. 11, 379.
35. Van den Buuse, M., S.J. Morton, J.L. Cornish and G.A. Head, 1996, Prolonged effects of quinpirole on cardiovascular regulation, J. Pharmacol. Exp. Ther. 277, 473.
36. Woods, R.L. and C.I. Johnston, 1983, Contribution of vasopressin to the maintenance of blood pressure during dehydration, Am. J. Physiol. 245, F615.
37. 2 receptors in the posterior region of the nucleus tractus solitarius mediate the central presser action of quinpirole (LY171555), Brain Res. Bull. 24, 97.